Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > A new company make mistakes, learn & change
View:
Post by Sarb99 on Feb 28, 2021 12:59am

A new company make mistakes, learn & change

No bad review is a good thing. A new company always makes many mistakes, and good companies learn from those mistakes and improve their services. Collection sites are only about three months old, a young company making mistakes. Also, in an industry with very high demand and expectations. No one wants to stand in the lineup, everyone wants a result sent the same day. Collection sites as a new company do not have that many resources to meet the demand. Especially when a new company is trying to figure out how many people are coming for testings. How many staff people they need at collection sites and in the lab to offer the best services. Slowly, they will get better. https://a.flexbooker.com/widget/67a9bda2-bd71-43cb-aead-9015cb033887?locationId=20853#bookFixed

 

You can see they are learning and making changes. Most of the complaints were s for PCR results times and now testbeforeyougo.com says "please confirm turnaround times first. Result times are not guaranteed." That is before you make an online booking. Some complaints were about small cubes instead of the big office. Collection sites have cubes pictures and written on the websites and in the news. So, complaining about cubes instead of offices is not justified. It seems to solve staff not behaving problem, collection sites started hiring managers.

 

In the last webinar, Medivolve said they have about 200k customers that mean about 200k test done. So, percentage-wise these complaints are not a big part of all performed tests. In any case, collection site management needs to look into these complaints and make needed changes to stay a trusted company. 

Comment by CerealKiller on Feb 28, 2021 2:13am
Uh oh, knowszero is going to label you a basher since you agreed that negative reviews are a bad thing and something Medivolve needs to get on top of. (For the record, I agree with your post and that it's growing pains. They will/should improve in this area with time.)
Comment by maidenmist on Feb 28, 2021 10:18am
Any idea when we can watch the replay of the webinar? By most accounts based on posts on this board, wasnt much but I'd like to view it anyway.
Comment by Rambo84 on Feb 28, 2021 3:07pm
Someone hook maiden up. I don't know how to 
Comment by maidenmist on Feb 28, 2021 9:03pm
Yes. Please hook me up. Thanks
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities